论文信息 - The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.

The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.

OBJECTIVE The purpose of our study was to compare the major prognostic factors (tumor size, axillary lymph node status, and tumor stage) of breast cancers detected at mammographic screening in women ages 40-49 years old with those in women ages 50-64 years old. MATERIALS AND METHODS Study subjects were women ages 40-64 years old who participated in our mobile van mammographic screening program from April 1985 to June 1994. We retrospectively reviewed the clinical and pathology records of women in whom breast cancer was detected at mammographic screening. All examinations were performed with dedicated equipment using screen-film technique. RESULTS A total of 44,301 screening examinations were done during the study period. Seventy-five cancers were detected in women ages 40-49 years old, and 128 cancers were detected in women ages 50-64 years old. The cancer detection rate was 3.0 per 1000 examinations in the younger age group compared with 5.5 per 1000 examinations in the older age group. The median size of breast cancers was 10 mm for women ages 40-49 versus 11 mm for women ages 50-64. Eighty-eight percent of the patients in both age groups had no evidence of metastasis to axillary lymph nodes. Nineteen percent of women in the younger age group had advanced breast cancer (stage II or higher) compared with 26% of women ages 50-64 (p = .25). No statistically significant differences were noted between the two age groups in the size, lymph node status, or stage of breast cancers detected at mammographic screening. However, the cancers found in younger women had slightly more favorable prognoses. CONCLUSION The major prognostic factors of cancers detected with modern mammographic equipment appear to be at least as favorable for women ages 40-49 years old as for women ages 50-64 years old. As mammographic screening has already been shown to be beneficial for women ages 50-64 years old, screening should also be beneficial for women ages 40-49 years old.

[1] E A Sickles,et al. Quality assurance. How to audit your own mammography practice. , 1992, Radiologic clinics of North America.

[2] E A Sickles,et al. Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. , 1990, Radiology.

[3] C. J. Rosenquist,et al. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. , 1994, Radiology.

[4] B. Cady. Duct Carcinoma In Situ , 1993 .

[5] A. Miller,et al. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986 , 1989 .

[6] N Volkers. NCI replaces guidelines with statement of evidence. , 1994, Journal of the National Cancer Institute.

[7] D. Schapira,et al. Breast cancer screening and compliance and evaluation of lesions. , 1996, The Medical clinics of North America.

[8] S Shapiro,et al. Report of the International Workshop on Screening for Breast Cancer. , 1993, Journal of the National Cancer Institute.

[9] K. Kerlikowske,et al. Positive predictive value of screening mammography by age and family history of breast cancer. , 1993, JAMA.

[10] R E Hendrick,et al. Benefit of mammography screening in women ages 40 to 49 Years. Current evidence from randomized controlled trials , 1995, Cancer.